Reviewing the evidence for prescribing steroids for non-specific symptoms in patients with advanced cancer

Abstract

his article sets out to review the evidence for prescribing steroids for non-specific symptoms experienced by patients with advanced carcinoma. Factors influencing the prescription of steroids, for example, drug interactions and their side effects are explored. Furthermore the importance of including patients in prescribing decisions and promoting adherence is discussed. The evidence shows that the benefit of steroids is felt within a week of commencement but is usually not sustained much beyond two weeks. In practice there appears to be inconsistent prescribing and monitoring of steroids, creating a need for a change of practice to promote high quality care for patients.